ENTA has been in the news 900% more than usual
Sep 30, 2025, 10:31 PM
-11.14%
What does ENTA do
Enanta Pharmaceuticals, based in Watertown, Massachusetts, focuses on developing small molecule drugs for viral infections and liver diseases, including treatments for RSV and hepatitis C. The company went public in March 2013 and employs 145 people.
ENTA has been in the news recently: Enanta Pharmaceuticals, Inc. recently announced topline data from its Phase 2b study of zelicapavir for high-risk adults with RSV infection. Additionally, the company reported a 20% increase in revenue in the last quarter, attributed to strong sales and a growing customer base.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.